Findings align with existing safety data, supporting continued use of aluminium-adjuvanted vaccines in immunisation programmes. Current evidence does not support direct (causal) associations between aluminium adjuvanted vaccines and serious or long term health outcomes, including autism, diabetes and asthma, finds a review of the latest data published by The BMJ today. Small ...